Comparing blood thinners to prevent another stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests two different blood-thinning medicines to see which is better at preventing another stroke in people who recently had a stroke with no clear cause. The goal is to find a treatment that works well and is safe for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a stroke within the last 14 days and doctors haven't found a clear cause yet.
- You have at least one of these: a stroke affecting the outer part of the brain or multiple areas, a stroke that happened again or while on antiplatelet medicine, an enlarged left upper heart chamber, a weak heart pumping function, or many extra heartbeats.
- You do not have significant narrowing in the blood vessel that caused the stroke, a known heart source of clots, or a planned procedure to close a hole in the heart.
- You do not have active bleeding, a history of bleeding in the brain, severe kidney or liver problems, or a condition that requires you to take other blood thinners.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two blood thinners, edoxaban and apixaban, to see how they affect new brain lesions seen on MRI in people who have had a stroke and also have atrial fibrillation. It aims to find which might be safer for preventing future brain damage.
This study tests whether a common blood thinner (apixaban) alone is as safe and effective as combining it with another drug (clopidogrel) to prevent future strokes in people who have both atrial fibrillation and narrowing in the arteries leading to the brain. It aims to find the best way to reduce stroke risk while minimizing bleeding.
This study compares four different blood-thinning medicines (indobufen, aspirin, cilostazol, and clopidogrel) to see how well they prevent another stroke in people who recently had an ischemic stroke. It may help doctors choose the best option for each patient.
This study tests whether taking a blood thinner after a stroke is safe and helpful for people who have atrial fibrillation (an irregular heartbeat) and have had a bleeding stroke in the past. It aims to prevent future strokes while managing the risk of another brain bleed.
This study compares two blood-thinning medicines, edoxaban and apixaban, to see which one is better at preventing strokes and bleeding in people who have both atrial fibrillation and coronary artery disease. If you're eligible, you may receive one of these standard treatments, and the trial could help find the safer option.
This study compares two ways to lower the chances of another heart attack: taking the standard medicine (clopidogrel) versus taking a combination of aspirin and a lower dose of a blood thinner (rivaroxaban). If you join, you'll be assigned to one of these options to see which works better for people like you.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.